BRASILIA (Reuters) – Brazil’s health regulator Anvisa said it has scheduled a meeting on Sunday to decide on the emergency use of COVID-19 vaccines developed by China’s Sinovac Biotec and by AstraZeneca PLC jointly with Oxford University.
(Reporting by Anthony Boadle; Editing by Chris Reese)
